Interestingly, in our study, there was a significant upregulation of IL-10 and IL-15, consistently associated with disease severity in both investigated COVID-19 whole blood dataset and our cytokine assays, suggesting the potential utility of these predictive cytokines as circulating biomarkers of severity. The gene discussed is IL10; the disease is COVID-19.